Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • More Info: Shows full summary of content record
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Diabetes Mellitus Type 1
  Follow Topic   Edit Search
Your search returned 38 results
from the time period: last 90 days.
Sort by Relevance / Date Group By Journal / No Grouping
JAMA 
DescriptorName: Diabetes Mellitus, Type 1... AbstractText: Hypoglycemia, common in patients with type 1 diabetes, is a major barrier to achieving good glycemic control... risk difference, -6.8%; 95% CI, -10.8% to -2.7%) AbstractText: Among patients with type 1 diabetes and at least 1 risk factor for hypoglycemia, 32 weeks' treatment with ...
Endocrine Disorders (4)
Hypoglycemia (11), Diabetes Mellitus, Type 1 (4), Coma (1), more mentions
Diabetes care
... 60-min C-peptide levels) as prediagnostic end points for type 1 diabetes among Type 1 Diabetes TrialNet Pathway to Prevention Study participants AbstractText: Two cohorts were ... In contrast, HRs of IND/DYS- and type 1 diabetes with age and 30-0-min C-peptide were consistent ... without Index60 ≥1.00 is a suboptimal prediagnostic end point for type 1 diabetes.
Endocrine Disorders (9)
Diabetes Mellitus, Type 1 (9), more mentions
Diabetes care
AbstractText: Although patients with type 1 diabetes have a poor prognosis after a stroke, predictors of survival ... study, a total of 144 patients of 4,083 with type 1 diabetes from the Finnish Diabetic Nephropathy (FinnDiane) Study suffered an incident stroke in 1997-2010 ... cause mortality increased with deteriorating kidney function AbstractText: Patients with type 1 diabetes with an incident stroke have a poor cardiovascular prognosis and ...
Endocrine Disorders (6), Kidney Disease (2)
Diabetes Mellitus, Type 1 (4), Diabetic Nephropathies (2), Diabetes Mellitus (2), more mentions
Annals of internal medicine 
AbstractText: The American Diabetes Association (ADA) annually updates Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties ... based recommendations for the diagnosis and management of patients with diabetes AbstractText: For the 2017 Standards of Care, the ADA Professional ... Care about monitoring and pharmacologic approaches to glycemic management for type 1 diabetes.
Endocrine Disorders (7)
Diabetes Mellitus (5), Diabetes Mellitus, Type 1 (2), more mentions
Journal of the American College of Cardiology 
... percutaneous coronary intervention (PCI) may offer a survival benefit in patients with type 1 diabetes (T1D) in need of multivessel revascularization AbstractText: This study sought to determine ... in Heart disease Evaluated According to Recommended Therapies) register, the Swedish National Diabetes Register, and the Swedish National Patient Register to retrieve information about patient ...
Cardiovascular Diseases (5), Endocrine Disorders (3)
Myocardial Infarction (3), Coronary Disease (2), Heart Failure (2), more mentions
Diabetes care
Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,367 Individuals in the Diabetes Prospective Follow-up and T1D Exchange Registries..
Endocrine Disorders (4)
Diabetes Mellitus, Type 1 (2), Diabetes Mellitus (2), more mentions
Journal of the American College of Cardiology 
No summary available
Endocrine Disorders (1)
Diabetes Mellitus, Type 1 (1), more mentions
Diabetes care
Increasing Incidence but Decreasing Awareness of Type 1 Diabetes in Sweden..
Endocrine Disorders (2)
Diabetes Mellitus, Type 1 (2), more mentions
Diabetes care
High Illicit Drug Abuse and Suicide in Organ Donors With Type 1 Diabetes..
Endocrine Disorders (2)
Diabetes Mellitus, Type 1 (2), more mentions
Diabetic medicine : a journal of the British Diabetic Association 
... exists on the relationship between HbA1c variability and mortality in Type 1 diabetes... variability and mortality exists in a population of people with Type 1 diabetes... onset of first hospital admission between groups AbstractText: People with Type 1 diabetes were identified for inclusion from the Scottish Care Information - Diabetes data set ...
Endocrine Disorders (8)
Diabetes Mellitus, Type 1 (6), Diabetes Mellitus (2), more mentions
The New England journal of medicine
Background In most patients with type 1 diabetes, adequate glycemic control is not achieved with insulin therapy alone ... Conclusions Among patients with type 1 diabetes who were receiving insulin, the proportion of patients who achieved ... hemoglobin level lower than 7.0% with no severe hypoglycemia or diabetic ketoacidosis was larger in the group that received sotagliflozin than ...
Endocrine Disorders (7)
Diabetes Mellitus, Type 1 (5), Diabetic Ketoacidosis (4), Hypoglycemia (4), more mentions
Diabetes care
Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390..
Endocrine Disorders (4), Kidney Disease (2)
Chronic Kidney Diseases (2), Chronic Kidney Failure (2), Diabetes Mellitus, Type 1 (2), more mentions
Diabetes care
Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390..
Endocrine Disorders (4), Kidney Disease (2)
Chronic Kidney Diseases (2), Chronic Kidney Failure (2), Diabetes Mellitus, Type 1 (2), more mentions
Diabetes care
Comment on Gagnum et al. Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15-29 Years in Norway. Diabetes Care 2017;40:38-45..
Endocrine Disorders (4), Kidney Disease (2)
Chronic Kidney Failure (2), Diabetes Mellitus, Type 1 (2), Diabetes Mellitus (2), more mentions
Diabetes care
Response to Comment on Gagnum et al. Long-term Mortality and End-Stage Renal Disease in a Type 1 Diabetes Population Diagnosed at Age 15-29 Years in Norway. Diabetes Care 2017;40:38-45..
Endocrine Disorders (4), Kidney Disease (2)
Chronic Kidney Failure (2), Diabetes Mellitus, Type 1 (2), Diabetes Mellitus (2), more mentions
The New England journal of medicine
More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes..
Endocrine Disorders (2)
Diabetes Mellitus, Type 1 (2), more mentions
The New England journal of medicine
More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes..
Endocrine Disorders (2)
Diabetes Mellitus, Type 1 (2), more mentions
The New England journal of medicine
Intralymphatic Injection of Autoantigen in Type 1 Diabetes..
Endocrine Disorders (2)
Diabetes Mellitus, Type 1 (2), more mentions
The Journal of clinical endocrinology and metabolism
Context: Closed-loop control (CLC) for the management of T1D is a novel method for optimizing glucose control and strategies for individualized implementation are being developed. Objective: Analyze glycemic control in an Overnight CLC system designed to "reset" the patient to near normal glycemic targets every morning. Design: Randomized cross-over multicenter clinical trial. Participants: 44 subjects with T1D on insulin pump therapy. Intervention: Sensor-augmented pump therapy (SAP) at home vs 5 nights of CLC (active from 23:00 to 07:00) in a supervised outpatient setting (research house or hotel) with a substudy of 5 nights of CLC subsequently at home. Main Outcome Measure: Percent time spent in target range (70-180 mg/dL measured by CGM). Results: 40 subjects (age:45.5±9.5 years, HbA1c:7.4±0.8%) completed the study. Time in target range (70-180 mg/dL) significantly improved in CLC vs. SAP over 24 hours (78.3% vs. 71.4%, p=0.003) as well as overnight (85.7% vs. 67.6%, p<0.001). Time spent in a hypoglycemic range (<70 mg/dL) significantly decreased in CLC vs. SAP over 24 hours (2.5% vs. 4.3%, p=0.002) and overnight (0.9% vs. 3.2%, p<0.001). Mean glucose at 07:00 was lower with CLC vs. SAP (123.7 vs. 145.3 mg/dL, p<0.001). The substudy at home, involving 10 T1D subjects, showed similar trends with increased time in target (70-180 mg/dL) overnight (75.2% vs. 62.2%, p=0.07) and decreased time spent in hypoglycemic range (<70 mg/dL) overnight in CLC vs SAP (0.6% vs. 3.7%, p=0.03). Conclusion: Overnight-only CLC increased time in target range over 24 hours and decreased time in hypoglycemic range over 24 hours in a supervised outpatient setting. A pilot extension study at home showed a similar non-significant trend.
Endocrine Disorders (2)
Diabetes Mellitus, Type 1 (1), more mentions
Pancreas
... 6 (HHV6) A and B in human pancreata and to search for signs of active infection in this organ of subjects with and without type 1 diabetes (T1D).Pancreata from brain-dead organ donors with and without T1D were examined for the presence of HHV6 genomic sequences by polymerase chain reaction ...
Endocrine Disorders (2)
Diabetes Mellitus, Type 1 (2), Infections (2), more mentions
1 2  | Next Page»